149 related articles for article (PubMed ID: 24080462)
1. Towards boron neutron capture therapy: the formulation and preliminary in vitro evaluation of liposomal vehicles for the therapeutic delivery of the dequalinium salt of bis-nido-carborane.
Theodoropoulos D; Rova A; Smith JR; Barbu E; Calabrese G; Vizirianakis IS; Tsibouklis J; Fatouros DG
Bioorg Med Chem Lett; 2013 Nov; 23(22):6161-6. PubMed ID: 24080462
[TBL] [Abstract][Full Text] [Related]
2. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
3. Liposome formulations of o-carborane for the boron neutron capture therapy of cancer.
Olusanya TOB; Calabrese G; Fatouros DG; Tsibouklis J; Smith JR
Biophys Chem; 2019 Apr; 247():25-33. PubMed ID: 30797076
[TBL] [Abstract][Full Text] [Related]
4. Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy.
Miyajima Y; Nakamura H; Kuwata Y; Lee JD; Masunaga S; Ono K; Maruyama K
Bioconjug Chem; 2006; 17(5):1314-20. PubMed ID: 16984142
[TBL] [Abstract][Full Text] [Related]
5. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
6. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
[TBL] [Abstract][Full Text] [Related]
7. Unilamellar liposomes with enhanced boron content.
Li T; Hamdi J; Hawthorne MF
Bioconjug Chem; 2006; 17(1):15-20. PubMed ID: 16417247
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro evaluation of dequalinium B, a new boron carrier for neutron capture therapy (NCT).
Adams DM; Ji W; Barth RF; Tjarks W
Anticancer Res; 2000; 20(5B):3395-402. PubMed ID: 11131639
[TBL] [Abstract][Full Text] [Related]
9. Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective.
Nakamura H
Future Med Chem; 2013 Apr; 5(6):715-30. PubMed ID: 23617433
[TBL] [Abstract][Full Text] [Related]
10. Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers.
Koganei H; Ueno M; Tachikawa S; Tasaki L; Ban HS; Suzuki M; Shiraishi K; Kawano K; Yokoyama M; Maitani Y; Ono K; Nakamura H
Bioconjug Chem; 2013 Jan; 24(1):124-32. PubMed ID: 23214414
[TBL] [Abstract][Full Text] [Related]
11. Preparation and properties of nido-carborane-specific monoclonal antibodies for potential use in boron neutron capture therapy for cancer.
Pak RH; Primus FJ; Rickard-Dickson KJ; Ng LL; Kane RR; Hawthorne MF
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6986-90. PubMed ID: 7624355
[TBL] [Abstract][Full Text] [Related]
12. [Boron delivery system for neutron capture therapy of cancer].
Nakamura H
Rinsho Ketsueki; 2008 May; 49(5):294-301. PubMed ID: 18572805
[No Abstract] [Full Text] [Related]
13. Intracellular delivery and passive tumor targeting of a self-assembled nanogel containing carborane clusters for boron neutron capture therapy.
Kawasaki R; Sasaki Y; Akiyoshi K
Biochem Biophys Res Commun; 2017 Jan; 483(1):147-152. PubMed ID: 28039054
[TBL] [Abstract][Full Text] [Related]
14. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
Genady AR
Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
[TBL] [Abstract][Full Text] [Related]
15. Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy.
Lai CH; Lin YC; Chou FI; Liang CF; Lin EW; Chuang YJ; Lin CC
Chem Commun (Camb); 2012 Jan; 48(4):612-4. PubMed ID: 22114760
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.
Lee JD; Ueno M; Miyajima Y; Nakamura H
Org Lett; 2007 Jan; 9(2):323-6. PubMed ID: 17217295
[TBL] [Abstract][Full Text] [Related]
17. Substituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug delivery.
Yinghuai Z; Peng AT; Carpenter K; Maguire JA; Hosmane NS; Takagaki M
J Am Chem Soc; 2005 Jul; 127(27):9875-80. PubMed ID: 15998093
[TBL] [Abstract][Full Text] [Related]
18. Development of boron nanocapsules for neutron capture therapy.
Nakamura H; Ueno M; Ban HS; Nakai K; Tsuruta K; Kaneda Y; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S84-7. PubMed ID: 19406654
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy.
Stephenson SM; Yang W; Stevens PJ; Tjarks W; Barth RF; Lee RJ
Anticancer Res; 2003; 23(4):3341-5. PubMed ID: 12926073
[TBL] [Abstract][Full Text] [Related]
20. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
